Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Berges

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
European Urology|November 30, 2005
Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH studyN J A van Exel, M A Koopmanschap, J McDonnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Implication of cell kinetic changes during the progression of human prostatic cancerR R Berges, J Vukanovic, J I Epstein, et al.
Der Urologe. Ausg. A|November 1, 2015
[S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia]T Bschleipfer, T Bach, R Berges, et al.
Der Urologe. Ausg. A|November 1, 2015
[S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia]K Höfner, T Bach, R Berges, et al.
Nutrition and Cancer|January 1, 1996
Lack of tumor-promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communicationC Chaumontet, M Suschetet, E Honikman-Leban, et al.
Prostate Cancer and Prostatic Diseases|September 1, 2005
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertiseM Speakman, J Batista, R Berges, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2005
Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinionF C Lowe, J Batista, R Berges, et al.
Der Urologe. Ausg. A|August 5, 2003
[Prostate cancer diagnosis using ultrasound elastography. Introduction of a novel technique and first clinical results]H J Sommerfeld, J M Garcia-Schürmann, J Schewe, et al.
Der Urologe. Ausg. A|November 1, 2015
[Treatment mapping of prostate cancer in DVPZ prostate centers in Germany]R Berges, T Ebert, W Schafhauser, et al.
European Urology|October 4, 2002
Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph projectK M C Verhamme, J P Dieleman, G S Bleumink, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
European Urology|November 30, 2005
Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH studyN J A van Exel, M A Koopmanschap, J McDonnell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1995
Implication of cell kinetic changes during the progression of human prostatic cancerR R Berges, J Vukanovic, J I Epstein, et al.
Der Urologe. Ausg. A|November 1, 2015
[S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia]T Bschleipfer, T Bach, R Berges, et al.
Der Urologe. Ausg. A|November 1, 2015
[S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia]K Höfner, T Bach, R Berges, et al.
Nutrition and Cancer|January 1, 1996
Lack of tumor-promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communicationC Chaumontet, M Suschetet, E Honikman-Leban, et al.
Prostate Cancer and Prostatic Diseases|September 1, 2005
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertiseM Speakman, J Batista, R Berges, et al.
Prostate Cancer and Prostatic Diseases|June 15, 2005
Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinionF C Lowe, J Batista, R Berges, et al.
Der Urologe. Ausg. A|August 5, 2003
[Prostate cancer diagnosis using ultrasound elastography. Introduction of a novel technique and first clinical results]H J Sommerfeld, J M Garcia-Schürmann, J Schewe, et al.
Der Urologe. Ausg. A|November 1, 2015
[Treatment mapping of prostate cancer in DVPZ prostate centers in Germany]R Berges, T Ebert, W Schafhauser, et al.
European Urology|October 4, 2002
Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph projectK M C Verhamme, J P Dieleman, G S Bleumink, et al.
Pageof 4